The Ebola crisis overseas has come ashore to the United States, resulting in a series of effective public health responses and some high-visibility errors. Although the U.S. has had only one imported case from West Africa as of October 27, 2014 , several missteps in handling the case in Dallas, Texas, led to the release of an Ebola patient after initial presentation to a hospital emergency room, potential exposures of dozens of people, and the subsequent infection of two nurses. 1 One of the nurses with symptoms was permitted to fly on commercial airliners, placing hundreds of additional Americans at some risk of infection, albeit minimal. 2 Media coverage of the domestic "Ebola outbreak" 3 has fueled public concerns and the naming of America's first "Ebola Czar," Ron Klain. 4 The nation's preparedness capabilities are under question. 1 Dr. Georges Benjamin, Executive Director of the American Public Health Association, suggests that "[a] strong, well-developed and adequately funded public health system is the key to containing Ebola." 5 However, years of funding cuts, loss of personnel, and political apathy have stripped the public health system to its core even as expenditures for health care have risen exponentially. 1 U.S. public health agencies must rely on the frontline efforts of doctors, nurses, and other health workers equipped with sufficient legal authority and knowledge to control emerging health threats such as Ebola and protect the public's health. The stakes are high in the face of an infectious condition for which there is no approved vaccine or reliable treatment, and the fatality rate ranges from 30% to 70% globally. 6 In this column, two public health lawyers and two emergency medicine physicians who served together on the Institute of Medicine Crisis Standards of Care Committee from 2009 to 2012 7 share guidance on controversial topics at the intersection of law, medicine, and preparedness for Ebola, including (1) the willingness among health workers and entities to handle patients suspected or known to be infected; (2) novel treatments and administration of experimental drugs;
(3) implementation of isolation, quarantine, and other social-distancing measures in medical settings; and (4) prospective liabilities of health workers or entities for medical errors or omissions in the handling or treatment of Ebola cases.
HEALTH WORKER WILLINGNESS TO RESPOND
As with human immunodeficiency virus/acquired immunodeficiency syndrome, severe acute respiratory syndrome (SARS), the 2009 H1N1 influenza pandemic, and other epidemics, Ebola thrusts health workers into precarious situations that risk their safety or lives. In West Africa, more than 400 health workers have been infected with the virus, and 230 have died as of October 14, 2014. 8 Risks of exposure, infection, and death are not limited to affected regions in Africa. Several health workers in industrialized countries, including Spain 9 and the U.S., 1 have contracted Ebola despite access to personal protective equipment (PPE) and infection-control practices intended to prevent such outcomes. 10 These preventable infections led the U.S. Centers for Disease Control and Prevention (CDC) and state public health agencies to overhaul protocols for handling Ebola patients in hospitals and emergency medical services and lend their expertise early upon initial identification of suspect cases.
Health workers' duties to care for patients are well supported in law and ethics and are essential to the delivery of medical services. 11 However, these duties must be reconciled with the real risks faced by workers responding to Ebola. Frontline providers worry about their ability to deliver care safely with a paucity of appropriate training, limited experience in the use of PPE, questionable protection standards, 12 and hospital emergency management programs that have lost ground during the years since their robust development following 9/11. 13 The willingness of health workers to respond under dangerous conditions is predicated on system capacities to equip them with adequate PPE, training, knowledge, and supervision needed to remain safe.
Human resource policies must be sufficiently flexible to accommodate staff willing to volunteer to care for Ebola patients, as well as those who are unwilling due to personal health risks or concerns. Federal and state public health laws, employment contracts, and licensure standards may require health workers to provide care to Ebola patients. Patients arriving with emergency conditions at hospital emergency rooms are required to be screened and stabilized pursuant to the federal Emergency Medical Treatment and Active Labor Act (EMTALA). 14 Yet, legally mandating workers to handle patients is not preferable to seeking their voluntary efforts. Health workers treating Ebola patients to date at Emory University Hospital in Atlanta-one of the national treatment centers for cases of highly infectious diseases-act on their own volition with strong institutional support.
EXPERIMENTAL DRUGS AND TREATMENTS
Evaluating novel and relatively untested vaccines and therapeutics is challenging when nearly every intervention for Ebola is experimental. Successful patient outcomes may be equally attributable to supportive care as to any therapeutic drugs or specific interventions. Conducting randomized trials of potentially beneficial vaccines and medications is limited by a lack of prospective participants in developed countries and difficulty controlling for inconsistent, supportive care. Few Ebola patients would likely turn away available experimental therapies or care techniques when facing significant risks of mortality. Organizing a human clinical trial for a drug that few have received is problematic ethically when risks and benefits of participation cannot even be well described. Garnering truly informed consent from patients is complicated by the real threat of death.
In this climate, it may be appealing to try any experi-mental Ebola treatment or drug, but legal restrictions still prohibit the use of unapproved drugs or other therapies absent exceptions. The U.S. Food and Drug Administration (FDA) is authorized to allow the select use of experimental therapies through its powers to issue emergency use authorizations (e.g., Ebola assay tests), expedited investigational drug processes (e.g., brincidofovir), and limited exceptions for compassionate use (e.g., ZMapp). 15 Approvals through each of these exceptions entail a precise series of legal steps; failure to follow them results in access denials. Consistent with medical and public health ethics, as well as laws aimed at ensuring nondiscrimination in health care, providing experimental treatments that offer untold benefits or harms may be selective. Factoring in costs further muddles the issues. It takes millions of dollars to produce experimental drugs such as ZMapp. 16 Even if sufficient doses were available and affordable for a handful of patients in the U.S., tens of thousands of people in West Africa would be left untreated, which is patently inequitable. The current distribution of prior and existing Ebola treatments to citizens of first-world nations heightens sensitivities to the injustices underlying access to care, reflected by allegations surrounding the treatment of Liberian Thomas Eric Duncan, who died in Dallas on October 8, 2014. 17 Suggestions that costs and race considerations contributed to delays in applying for experimental treatments and providing aggressive care to Duncan are unproven. 18 If shown, however, legal liability under federal and state law would follow.
SOCIAL-DISTANCING MEASURES IN MEDICAL SETTINGS
Most patients who suspect they may have contracted Ebola will voluntarily seek medical care even if it includes temporary isolation from family and friends. If a suspected Ebola patient declines testing or treatment, health workers and public health agents may take legal action to minimize risks to the public's health.
Isolation of highly infectious patients is often accompanied by quarantine of related people exposed to the patient but who are not yet known to be infectious. As with Duncan and his contacts, these social-distancing powers are typically exercised pursuant to state or local public health laws. 19 Through its federal quarantine power, CDC has the legal tools needed to control importation and interstate transmission of specified communicable diseases, 20,21 but it typically uses these powers only at ports of entry or in time-sensitive situations. 22 Use of isolation or quarantine powers triggers significant due process interests of those impacted, including fair notice and rights to hearing, access to Law and the Public's Health  169
Public Health Reports / March-April 2015 / Volume 130 available treatment, adequate sustenance and housing, and appeals. 23 Some of these measures (e.g., right to hearing and appeals) may follow the initial application of isolation. Above all is the need to assure the safety of those subject to compulsory powers. Some of these requirements may be altered or expedited in exigencies. For example, Minnesota 24 and other states authorize ex parte orders (granted by a judge without a formal hearing or the parties' presence) to initiate or impose continued isolation in suspected or known cases, although nonconsensual treatments may not be required (except in cases of minors or wards of the state).
Health workers may also be subject to quarantine if they are exposed to Ebola at the workplace despite their use of PPE and adherence to strict protocols. Private hospitals and other health-care entities may ask hospital employees or others (not already infected with Ebola) who risk exposure due to their failure to adhere to infection-control policies to vacate the premises. During the 2003 SARS outbreak, health workers were instructed to self-quarantine as needed unless they developed fever and other symptoms for which they may become infectious. 25 Nurses and other staff in Dallas who treated Duncan were placed under limited quarantine orders, including travel restrictions, after two tested positive for Ebola.
Application of isolation or quarantine orders promotes public health and safety of patients, contacts, and workers. They are nonpunitive unless someone attempts to evade orders in ways that place others at direct risk. In such rare cases, evasion may be criminally prosecuted either as a contempt of court violation or pursuant to specific sanctions.
In the event of an Ebola outbreak in any U.S. community, public health agencies may utilize more extensive social-distancing measures pursuant to emergency declarations. The U.S. Department of Health and Human Services, along with 26 states and many larger municipal governments, can declare states of "public health emergency." 26 Connecticut was the first state to do so in response to Ebola on October 6, 2014. 27 Other jurisdictions may declare general states of disaster or emergency. Emergency public health powers not only heighten response capabilities and allow temporary legal waivers of potential impediments, they can also alter the legal liability landscape.
POTENTIAL LIABILITIES OF HEALTH WORKERS AND ENTITIES
Uncertainties concerning how easily Ebola spreads, as well as optimal treatment and safety protocols, contribute to liability concerns among hospitals and health providers. The specter of liability hangs heavy over actors and entities attempting to navigate successful handling and treatment of Ebola patients in health-care environments. 7 Claims may extend from actions or failures to act. Doctors who misdiagnose, delay treatments, or attempt to treat Ebola patients with experimental treatments or drugs that lack efficacy leading to patient harms may face allegations of medical malpractice or wrongful death. Workers exposed to Ebola in health-care settings are entitled to compensation. Those refusing to handle or treat Ebola patients despite adequate training and PPE may be subject to claims of disability discrimination, potential licensure sanctions, or termination. Hospital emergency departments turning away suspect patients without adequate screening or stabilization may face government penalties as well as institutional liability under EMTALA. 14 Hospital administrators who fail to plan adequately for Ebola cases may be liable for their omissions. 28 Liability risks are real but avoidable. Adequate advance planning obviates many claims through assurances of appropriate care and the use of PPE to prevent subsequent harms, 29 including infection of health workers handling Ebola patients. EMTALA sanctions can be avoided through screening protocols and/or advance agreements of specialist treatment centers to accept consensual transfers of patients, space permitting. Localized outbreaks or limits of safe and efficacious medical interventions may lend to implementation of crisis standards of care. Resulting shifts in the allocation of limited resources and concomitant changes in medical standards can diminish legal malpractice claims. 7 If additional governments formally declare states of emergency, explicit liability protections for health workers and entities take effect for the duration of the declaration in many jurisdictions. 23 These protections may negate claims grounded in negligence for real-time decisions or actions of workers in the throes of medical triage, as well as alleged scope of practice violations or breaches of health information privacy protections. Expansion of broad liability protections during emergencies encourages workers' response efforts without fear of retaliation for potential, unintended harms. 7
CONCLUSION
Cases of highly infectious diseases such as Ebola with significant mortality rates heighten public health concerns. Mitigating these fears entails affirmative public health and health-care responses undergirded by the judicious use of legal tools and options to protect the safety of health workers and communities and provide patients and contacts with comprehensive medical and public health services. Balancing duties and risks at the intersection of law, medicine, and preparedness is about assuring optimal and compassionate treatments for those who are ill and preserving the public's health.
